Increased risk of obesity related to total energy intake with the APOA5-1131T > C polymorphism in Korean premenopausal women

Nutrition Research

Volumn 34, Issue 10, 2014, Pages 827-836

  Lim, Hyo Hee ^a,b   Choi, Miok ^a   Kim, Ji Young ^c   Lee, Jong Ho ^d   Kim, Oh Yoen ^a  

^a Dong A University   (South Korea)

^b Korea Centers for Disease Control and Prevention   (South Korea)

^c Woosong University   (South Korea)

^d Yonsei University   (South Korea)

Author keywords

APOA5 1131T > C; Body mass index; Human; Obesity; Total energy intake

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A5; APOLIPOPROTEIN B; CYTOSINE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; THYMINE; TRIACYLGLYCEROL; APOA5 PROTEIN, HUMAN; APOLIPOPROTEIN A;

ADULT; AGE; ALCOHOL CONSUMPTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CHOLESTEROL BLOOD LEVEL; DIETARY INTAKE; DISEASE PREDISPOSITION; ENERGY EXPENDITURE; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; KOREAN (PEOPLE); MACRONUTRIENT; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; YOUNG ADULT; ANTHROPOMETRY; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; DIET; ENERGY METABOLISM; GENETICS; HOMOZYGOTE; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH KOREA;

ADULT; ANTHROPOMETRY; APOLIPOPROTEINS A; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CHOLESTEROL, HDL; DIET; ENERGY INTAKE; ENERGY METABOLISM; FEMALE; GENE FREQUENCY; GENOTYPE; HOMOZYGOTE; HUMANS; OBESITY; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PREMENOPAUSE; REPUBLIC OF KOREA; RISK; TRIGLYCERIDES;

EID: 84927661923     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2014.08.018     Document Type: Article

References (60)

1. Schaap F.G., Rensen P.C., Voshol P.J., Vrins C., van der Vliet H.N., Chamuleau R.A., et al. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J Biol Chem 2004, 279:27941-27947.
2. Fruchart-Najib J., Bauge E., Niculescu L.S., Pham T., Thomas B., Rommens C., et al. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5. Biochem Biophys Res Commun 2004, 319:397-404.
3. Pennacchio L.A., Olivier M., Hubacek J.A., Cohen J.C., Cox D.R., Fruchart J.C., et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 2001, 294:169-173.
4. Pennacchio L.A., Olivier M., Hubacek J.A., Krauss R.M., Rubin E.M., Cohen J.C. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride concentrations. Hum Mol Genet 2002, 11:3031-3038.
5. Aouizerat B.E., Kulkarni M., Heilbron D., Drown D., Raskin S., Pullinger C.R., et al. Genetic analysis of a polymorphism in the human apoA-V gene: effect on plasma lipids. J Lipid Res 2003, 44:1167-1173.
6. Endo K., Yanagi H., Araki J., Hirano C., Yamakawa-Kobayashi K., Tomura S. Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride concentration in Japanese schoolchildren. Hum Genet 2002, 111:570-572.
7. Baum L., Tomlinson B., Thomas G.N. APOA5-1131TNC polymorphism is associated with triglyceride concentrations in Chinese men. Clin Genet 2003, 63:377-379.
8. Jang Y., Kim J.Y., Kim O.Y., Lee J.E., Cho H., Ordovas J.M., et al. The -1131T > C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men. Am J Clin Nutr 2004, 80:832-840.
9. Bi N., Yan S.K., Li G.P., Yin Z.N., Chen B.S. A single nucleotide polymorphism -1131T > C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese. Mol Genet Metab 2004, 83:280-286.
10. Nabika T., Nasreen S., Kobayashi S., Masuda J. The genetic effect of the apoprotein AV gene on the serum triglyceride level in Japanese. Atherosclerosis 2002, 165:201-204.
11. Evans D., Buchwald A., Beil F.U. The single nucleotide polymorphism -1131T > C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia. J Mol Med 2003, 81:645-654.
12. Ribalta J., Figuera L., Fernandez-Ballart J., Vilella E., Castro Cabezas M., Masana L., et al. Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. Clin Chem 2002, 48:1597-1600.
13. Hubacek J.A. Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants. Clin Chem Lab Med 2005, 43:897-902.
14. Chandak G.R., Ward K.J., Yajnik C.S., Pandit A.N., Bavdekar A. Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to Europeans. BMC Med Genet 2006, 7:76.
15. Lai C.Q., Parnell L.D., Ordovas J.M. The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk. Curr Opin Lipidol 2005, 16:153-166.
16. Dallongeville J., Cottel D., Wagner A., Ducimetière P., Ruidavets J.B., Arveiler D., et al. The APOA5 Trp19 allele is associated with metabolic syndrome via its association with plasma triglycerides. BMC Med Genet 2008, 84:1-9.
17. Lai C.Q., Tai E.S., Tan C.E., Cutter J., Chew S.K., Zhu Y.P., et al. The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 2003, 44:2365-2373.
18. Talmud P.J., Hawe E., Martin S., Olivier M., Miller G.J., Rubin E.M., et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 2002, 11:3039-3046.
19. Hubacek J.A., Skodová Z., Adámková V., Lánská V., Poledne R. The influence of APOAV polymorphisms (T-1131 > C and S19 > W) on plasma triglyceride levels and risk of myocardial infarction. Clin Genet 2004, 65:126-130.
20. Szalai C., Keszei M., Duba J., Prohászka Z., Kozma G.T., Császár A., et al. Polymorphism in the promoter region of the apolipoprotein A5 gene is associated with an increased susceptibility for coronary artery disease. Atherosclerosis 2004, 173:109-114.
21. Lai C.Q., Demissie S., Cupples L.A., Zhu Y., Adiconis X., Parnell L.D., et al. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res 2004, 45:2096-2105.
22. Hsu L.A., Ko Y.L., Chang C.J., Hu C.F., Wu S., Teng M.S., et al. Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. Atherosclerosis 2006, 185:143-149.
23. Jang Y., Paik J.K., Hyun Y.J., Chae J.S., Kim J.Y., Choi J.R., et al. The apolipoprotein A5-1131T > C promoter polymorphism in Koreans: association with plasma APOA5 and serum triglyceride concentrations, LDL particle size and coronary artery disease. Clin Chim Acta 2009, 402:83-87.
24. Hubacek J.A., Kovár J., Skodová Z., Pit'ha J., Lánská V., Poledne R. Genetic analysis of APOAV polymorphisms (T-1131/C, Ser19/Trp and Val153/Met): no effect on plasma remnant particles concentrations. Clin Chim Acta 2004, 348:171-175.
25. Lee K.W., Ayyobi A.F., Frohlich J.J., Hill J.S. APOA5 gene polymorphism modulates levels of triglyceride, HDL cholesterol and FERHDL but is not a risk factor for coronary artery disease. Atherosclerosis 2004, 176:165-172.
26. Mar R., Pajukanta P., Allayee H., Groenendijk M., Dallinga-Thie G., Krauss R.M., et al. Association of the apolipoprotien A1/C3/A4/A5 gene cluster with triglyceride levels and LDL particle size in familial combined hyperlipidemia. Circ Res 2004, 94:993-999.
27. Niculescu L.S., Fruchart-Najib J., Fruchart J.C., Sima A. Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome. Clin Chem Lab Med 2007, 45:1133-1139.
28. Horvatovich K., Bokor S., Barath A., Maasz A., Kisfali P., Járomi L., et al. Haplotype analysis of the apolipoprotein A5 gene in obese pediatric patients. Int J Pediatr Obes 2011, 6:e318-e325.
29. Corella D., Lai C.Q., Demissie S., Cupples L.A., Manning A.K., ker K.L., et al. APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study. J Mol Med 2007, 85:119-128.
30. Aberle J., Evans D., Beil F.U., Seedorf U. A polymorphism in the apolipoprotein A5 gene is associated with weight loss after short-term diet. Clin Genet 2005, 68:152-154.
31. Mello M.M., Studdert D.M., Brennan T.A. Obesity-the new frontier of public health law. N Engl J Med 2006, 354:2601-2610.
32. Hossain P., Kawar B., El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med 2007, 356:213-215.
33. Shuldiner A.R. Obesity genes and gene-environment-behavior interactions: recommendations for a way forward. Obesity 2008, 16:S79-S81.
34. Chronic Disease Surveillance Team The Korean National Health and Nutrition Survey 2007, Seoul, Korea, Korea centers for disease control and prevention.
35. Zhu W.F., Wang C.L., Liang L., Shen Z., Fu J.F., Liu P.N., et al. Triglyceride-raising APOA5 genetic variants are associated with obesity and non-HDL-C in Chinese children and adolescents. Lipids Health Dis 2014, 13:93.
36. The Third Korea National Health and Nutrition Examination Survey (KNHANES) 2011, Korea Centers for Disease Control and Prevention, Seoul.
37. National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002, 106:3143-3421.
38. World Health Organization The Asian Pacific perspective: redefining obesity and its treatment 2000, Health Communications Australia Pty Ltd.
39. American Diabetes Association Standards of medical care in diabetes-2010. Diabetes Care 2010, 33:s11-s61.
40. Talmud P.J., Martin S., Taskinen M.R., Frick M.H., Nieminen M.S., Äniemi Y.A., et al. APOA5 gene variants, lipoprotein particle distribution, and progression of coronary heart disease: results from the LOCAT study. J Lipid Res 2004, 45:750-756.
41. Song J., Kwon N., Lee M.H., Koh Y., Lee J.H., Kim O.Y. Association of serum phospholipid PUFAs with cardiometabolic risk: beneficial effect of DHA on the suppression of vascular proliferation/inflammation. Clin Biochem 2014, 47:361-368.
42. Shim J.S., Oh K.W., Suh I. A study on validity of a 299 semiquantitative food frequency questionnaire of Korean adults. Korean J Commun Nutr 2002, 7:484-494.
43. Christian J.L., Greger J.L. Nutrition for Living 1994, 111. Benjamin/Cummings, Redwood City, CA.
44. The American Dietetic Association Handbook of clinical dietetics 1992, 5-39. Yale University Press, New Haven, CT. 2nd ed.
45. Sánchez-Moreno C.1., Ordovás J.M., Smith C.E., Baraza J.C., Lee Y.C., Garaulet M. APOA5 gene variation interacts with dietary fat intake to modulate obesity and circulating triglycerides in a Mediterranean population. J Nutr 2011, 141:380-385.
46. van den Berg S.A., Heemskerk M.M., Geerling J.J., van Klinken J.B., Schaap F.G., Bijland S., et al. Apolipoprotein A5 deficiency aggravates high-fat diet-induced obesity due to impaired central regulation of food intake. FASEB J 2013, 27:3354-3362.
47. Schwinkendorf D.R., Tsatsos N.G., Gosnell B.A., Mashek D.G. Effects of central administration of distinct fatty acids on hypothalamic neuropeptide expression and energy metabolism. Int J Obes 2011, 35:336-344.
48. Guardiola M., Alvaro A., Vallve J.C., Rosales R., Sola R., Girona J., et al. APOA5 gene expression in the human intestinal tissue and its response to in vitro exposure to fatty acid and fibrate. Nutr Metab Cardiovasc Dis 2005, 22:756-762.
49. Dichlberger A., Cogburn L.A., Nimpf J., Schneider W.J. Avian apolipoprotein A-V binds to LDL receptor gene family members. J Lipid Res 2007, 48:1451-1456.
50. Mortazavi A., Williams B.A., McCue K., Schaeffer L., Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008, 5:621-628.
51. Shimogori T., Lee D.A., Miranda-Angulo A., Yang Y., Wang H., Jiang L., et al. A genomic atlas of mouse hypothalamic development. Nat Neurosci 2010, 13:767-775.
52. Fox P.T., Lancaster J.L. Mapping context and content: the BrainMap model. Nat Rev Neurosci 2002, 3:319-321.
53. Van der Vliet H.N., Sammels M.G., Leegwater A.C., Levels J.H., Reitsma P.H., Boers W., et al. Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration. J Biol Chem 2001, 276:44512-44520.
54. Genoux A., Dehondt H., Helleboid-Chapman A., Duhem C., Hum D.W., Martin G., et al. Transcriptional regulation of apolipoprotein A5 gene expression by the nuclear receptor ROR. Arterioscler Thromb Vasc Biol 2005, 25:1186-1192.
55. Wolfgang M.J., Lane M.D. The role of hypothalamic malonyl-CoA in energy homeostasis. J Biol Chem 2006, 81:37265-37269.
56. Morgan K., Obici S., Rossetti L. Hypothalamic responses to long-chain fatty acids are nutritionally regulated. J Biol Chem 2004, 279:31139-31148.
57. Perez-Martinez P., Corella D., Shen J., Arnett D.K., Yiannakouris N., Tai E.S., et al. Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial, and fenofibrate-treated states. Am J Clin Nutr 2009, 89:391-399.
58. Vaessen S.F., Schaap F.G., Kuivenhoven J.A., Groen A.K., Hutten B.A., Boekholdt S.M., et al. Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study. J Lipid Res 2006, 47:2064-2070.
59. Hsu M.C., Chang C.S., Lee K.T., Sun H.Y., Tsai Y.S., Kuo P.H., et al. Central obesity in males affected by a dyslipidemia-associated genetic polymorphism on APOA1/C3/A4/A5 gene cluster. Nutr Diabetes 2013, 3:e61.
60. Rimm E.B., Giovannucci E.L., Stampfer M.J., Colditz G.A., Litin L.B., Willett W.C. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 1992, 135:1114-1126.